AZTA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $38.75
Market Cap (MRQ) $1.70B
P/E (TTM) -14.5
EPS (TTM) $-2.67
Revenue (TTM) $614M
ROE (TTM) -7.7%
52W Range $16–$42

AZTA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Azenta, Inc. - Common Stock Company overview from Wikipedia

05 · wikidata
sectorHealthcare industryLife Sciences Tools & Services employees2,900 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$594M
2019-09-30 → 2025-09-30
EPS$-1.22
2019-09-30 → 2025-09-30
Free Cash Flow$38M
2019-09-30 → 2025-09-30
Net margin-20.0%
2019-09-30 → 2025-09-30
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend AZTA 5Y avg Peer Median Verdict
P/E (TTM) -14.5 · · ·
P/S (TTM) 2.8 · 4.3 Undervalued
P/B (MRQ) 1.1 · 3.0 Undervalued
Price / FCF (TTM) 171.6 · · ·
Price / Cash Flow (TTM) 44.7 · 18.2 Fair value
Price / Tangible Book (MRQ) 1.2 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13
Annualized Payout≈$0.40Paid quarterly
Ex-dateAmountCurrencyYield
Dec 2, 2021$0.10USD≈0.37%
Sep 2, 2021$0.10USD≈0.47%
Jun 3, 2021$0.10USD≈0.41%
Mar 4, 2021$0.10USD≈0.52%
Dec 3, 2020$0.10USD≈0.56%
Sep 3, 2020$0.10USD≈0.82%
Jun 4, 2020$0.10USD≈0.93%
Mar 5, 2020$0.10USD≈1.2%
Dec 5, 2019$0.10USD≈0.98%
Sep 5, 2019$0.10USD≈1.1%
Jun 6, 2019$0.10USD≈1.0%
Feb 28, 2019$0.10USD≈1.2%
Dec 6, 2018$0.10USD≈1.4%
Sep 6, 2018$0.10USD≈1.1%
May 31, 2018$0.10USD≈1.2%
Mar 1, 2018$0.10USD≈1.5%
Nov 30, 2017$0.10USD≈1.6%
Sep 7, 2017$0.10USD≈1.5%
May 31, 2017$0.10USD≈1.5%
Mar 1, 2017$0.10USD≈1.9%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -19.2%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 $0.16 $0.12 37.8%
March 31, 2026 $-0.04 $0.13 -131.7%
Dec. 31, 2025 $0.09 $0.14 -35.9%
Sept. 30, 2025 $0.21 $0.19 8.6%
June 30, 2025 $0.19 $0.14 36.2%
March 31, 2025 $0.05 $0.07 -30.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 18
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $594M$573M$551M$555M$514M$389M$334M$632M$527M$434M$553M$483M
Cost of Revenue $324M$319M$312M$300M$270M$216M$200M$385M$329M$277M$364M$316M
Gross Profit $270M$255M$239M$256M$244M$172M$135M$246M$199M$157M$189M$167M
R&D Expense $30M$32M$32M$28M$22M$18M$17M$47M$40M$44M$52M$53M
SG&A Expense $262M$263M$264M$251M$252M$190M$163M$167M$142M$119M$115M$111M
Operating Expenses $297M$306M$300M$280M$275M$209M$182M$215M$185M$174M$172M$170M
Operating Income $-27M$-51M$-61M$-25M$-31M$-37M$-47M$31M$14M$-17M$17M$-3M
Interest Expense ···$5M$2M$3M$22M$10M$408.0K$157.0K$395.0K$202.0K
Interest Income ·$33M$44M$16M·····$452.0K$899.0K$950.0K
Other Non-op $922.0K$-732.0K$-2M$-898.0K$-16M$-2M$-1M$-3M$-2M$-1M$421.0K$256.0K
Pretax Income $-7M$-19M$-20M$-10M$-49M$-40M$-84M$20M$15M$-18M$18M$-2M
Income Tax $-32M$5M$-12M$1M$-20M$-14M$-23M$-47M$3M$66M$3M$-2M
Net Income $-56M$-165M$-15M$2.13B$111M$65M$437M$117M$63M$-69M$14M$31M
EPS (Basic) $-1.22$-3.10$-0.22$28.48$1.49$0.88$6.08$1.65$0.90$-1.01$0.21$0.47
EPS (Diluted) $-1.22$-3.10$-0.22$28.48$1.49$0.88$6.04$1.64$0.89$-1.01$0.21$0.46
Shares (Basic) 45,743,00053,175,00066,253,00074,897,00074,229,00073,557,00071,992,00070,489,00069,575,00068,507,00067,411,00066,648,000
Shares (Diluted) 45,896,00053,175,00066,253,00074,897,00074,455,00073,850,00072,386,00070,937,00070,485,00068,507,00068,549,00067,644,000
EBITDA $-27M$-201M$-73M$-25M$-31M$78M$46M$31M$64M$4M$17M$-3M
Balance Sheet 29
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $280M$280M$649M$658M$227M$251M$257M$198M$102M$85M$81M$94M
Short-term Investments ·······$46M$28.0K$39.0K$70M$68M
Receivables $142M$154M$157M$164M$120M$95M$166M$125M$93M$106M$86M$80M
Inventory $75M$71M$128M$86M$60M$37M$99M$97M$73M$93M$101M$94M
Prepaid Expense $65M$51M$99M$133M$51M$44M$46M$32M$23M$15M$15M$19M
Current Assets $708M$833M$1.42B$2.46B$777M$649M$647M$564M$352M$299M$356M$374M
PP&E (Net) ······$101M$60M$57M$55M$42M$50M
PP&E (Gross) ······$251M$191M$175M$195M$169M$174M
Accum. Depreciation ······$151M$131M$118M$140M$127M$124M
Goodwill $702M$691M$675M$514M$469M$453M$441M$256M$207M$176M$121M$110M
Intangibles $102M$125M$294M$178M$187M$212M$251M$100M$84M$82M$55M$60M
Other Non-current Assets $6M$11M$4M$57M$58M$50M$21M$5M$6M$12M$9M$5M
Total Assets $2.06B$2.10B$2.89B$3.72B$1.82B$1.56B$1.52B$1.10B$767M$686M$759M$778M
Accounts Payable $38M$33M$36M$39M$42M$26M$59M$45M$49M$41M$45M$34M
Current Liabilities $238M$206M$211M$231M$345M$211M$272M$165M$147M$120M$113M$114M
Capital Leases $51M$57M$60M$49M$45M$19M····$0$7M
Deferred Tax $18M$18M$67M$65M$13M$18M$21M$7M$4M$3M$3M$3M
Other Non-current Liabilities $11M$9M$12M$7M$6M$1M$10M$6M$4M$4M$3M$4M
Total Liabilities $333M$332M$351M$353M$494M$346M$377M$377M$159M$132M$127M$135M
Long-term Debt ····$50M$50M$51M$196M····
Total Debt ····$50M$50M$51M$196M····
Common Stock $594.0K$590.0K$713.0K$885.0K$878.0K$873.0K$857.0K$841.0K$833.0K$821.0K$811.0K$804.0K
Paid-in Capital $530M$506M$1.16B······$1.86B$1.85B$1.83B
Retained Earnings $1.42B$1.48B$1.64B$1.66B$-470M$-551M$-586M$-994M$-1.08B$-1.12B$-1.02B$-1.01B
Treasury Stock $201M$201M$201M$201M$201M$201M$201M$201M$201M$201M$201M$201M
AOCI $-22M$-13M$-62M$-84M$19M$22M$4M$14M$15M$15M$6M$16M
Stockholders' Equity $1.73B$1.77B$2.53B$3.36B$1.33B$1.21B$1.14B$718M$608M$554M$632M$643M
Liabilities + Equity $2.06B$2.10B$2.89B$3.72B$1.82B$1.56B$1.52B$1.10B$767M$686M$759M$778M
Shares Outstanding 45,858,97945,570,08457,832,37888,482,12587,808,92287,293,71085,759,70084,164,13083,294,84882,220,27081,093,05280,375,777
Cash Flow 18
Metric Trend 202520242023202220212020201920182017201620152014
D&A $61M$91M$86M$54M$65M$65M$54M$37M$28M$28M$25M$23M
Stock-based Comp $21M$14M$9M$11M$27M$16M$20M$20M$17M$12M$12M$11M
Deferred Tax $-27M$-16M$-29M$24M$-17M$-5M$-15M$-45M$517.0K$70M$-2M$-2M
Amort. of Intangibles $24M$29M$32M$32M$37M$35M$27M$24M$17M$15M$13M$11M
Restructuring $5M$7M$5M$712.0K$385.0K$674.0K$1M$714.0K$3M$10M$5M$6M
Operating Cash Flow $72M$50M$6M$-466M$150M$38M$91M$74M$96M$40M$44M$54M
CapEx $34M$37M$39M$73M$53M$40M$24M$13M$13M$13M$16M$6M
Investing Cash Flow $-90M$225M$431M$1.47B$-146M$-23M$211M$-148M$-54M$-11M$-18M$-18M
Net Debt Issued ·$0··········
Stock Issued $3M$3M$4M$5M$6M$5M$3M$3M$2M$2M$2M·
Stock Repurchased $0$662M$839M$0········
Net Stock Activity $3M$-658M$-839M$5M$6M$5M$3M$3M$2M···
Dividends Paid ·$0$0$7M$30M$30M$29M$28M$28M$28M$27M$23M
Financing Cash Flow $-10M$-659M$-840M$-63M$-26M$-27M$-191M$170M$-26M$-26M$-34M$-24M
Net Change in Cash $-24M$-363M$-357M$756M$-17M$-3M$107M$96M$17M$4M$-13M$11M
Taxes Paid $7M$3M$43M$452M$38M$102M$17M$21M$8M$5M$4M$1M
Free Cash Flow $38M$13M$-22M$-539M$97M$-2M$67M$61M$84M$27M$28M$48M
Levered FCF ···$-545M$96M$-5M$45M$30M$83M$30M$27M$48M
Profitability 8
Metric Trend 202520242023202220212020201920182017201620152014
Gross Margin 45.5%40.1%39.6%46.0%47.5%42.4%40.5%39.0%38.6%35.4%34.2%34.7%
Operating Margin -4.5%-30.6%-11.0%-4.5%-6.0%8.7%5.9%5.0%9.2%0.76%3.1%-0.56%
Net Margin -9.4%-25.0%-2.1%383.9%21.6%7.2%56.0%18.5%9.0%-12.4%2.6%6.5%
Pretax Margin -1.2%-25.5%-4.6%-1.8%-9.5%8.4%1.2%3.2%9.4%0.71%3.2%-0.35%
EBITDA Margin -4.5%-30.6%-11.0%-4.5%-6.0%8.7%5.9%5.0%9.2%0.76%3.1%-0.56%
ROA -2.7%-6.6%-0.43%77.1%6.6%4.2%33.5%12.5%8.6%-9.6%1.8%4.1%
ROE -3.3%-8.7%-0.54%62.5%8.4%5.4%46.6%16.3%10.8%-11.7%2.2%4.9%
ROIC 5.3%-11.1%-1.2%-0.84%-1.3%5.4%3.9%11.4%8.6%-13.9%2.2%0.07%
Liquidity & Solvency 5
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 3.04.16.710.72.33.12.43.42.42.53.33.3
Quick Ratio 1.82.44.03.61.02.31.72.21.51.62.12.1
Debt / Equity ····0.00.00.00.3····
LT Debt / Equity ····0.00.00.00.3····
Interest Coverage ···-5.4-15.326.72.13.3157.127.042.8-13.4
Efficiency 3
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 0.30.30.20.20.30.60.60.71.00.80.70.6
Inventory Turnover 4.23.23.84.15.54.84.74.54.33.83.73.4
Receivables Turnover 4.14.04.23.94.85.15.45.86.15.86.66.1
Per Share 6
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $37.66$38.82$43.82$44.83$17.83$16.44$15.75$10.15$8.70$8.05$9.35$9.61
Revenue / Share $12.94$12.34$10.04$7.42$6.90$12.15$10.79$8.90$9.83$8.18$8.06$7.14
Cash Flow / Share $1.57$0.95$0.26$-6.22$2.01$0.51$1.26$1.04$1.37$0.58$0.64$0.80
Cash / Share $6.10$6.82$11.74$8.77$3.06$4.00$4.17$2.80$1.46$1.24$1.19$1.41
Dividend / Share ···$0.10$0.40$0.40$0.40$0.40$0.40$0.40$0.40$0.34
EPS (TTM) $-1.22$-3.10$-0.22$28.48$1.49$0.88$6.04$1.64$0.89$-1.01$0.21$0.46
Growth Rates 5
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 3.5%4.0%-0.72%8.1%32.2%·······
Revenue CAGR 3Y 2.2%3.7%12.4%·········
Revenue CAGR 5Y 8.8%···········
EPS YoY ···1811.4%69.3%·······
Net Income YoY ···1825.9%70.8%·······
Valuation (TTM) 17
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $594M$573M$551M$555M$514M$389M$334M$632M$527M$434M$553M$483M
Net Income TTM $-56M$-165M$-15M$2.13B$111M$65M$437M$117M$63M$-69M$14M$31M
Market Cap $1.32B$2.21B$2.90B$3.22B$7.61B$3.42B$2.68B$2.48B$2.12B$936M$792M$703M
Enterprise Value ····$7.43B$3.17B$2.43B$2.43B····
P/E -23.5-15.6-228.11.568.752.66.121.434.1-13.555.822.8
P/S 2.23.85.35.814.88.88.03.94.02.21.41.5
P/B 0.81.21.11.05.72.82.43.53.51.71.31.1
P / Tangible Book 1.42.31.91.211.46.2······
P / Cash Flow 18.243.9166.0-6.950.890.229.533.522.023.718.113.1
P / FCF 34.4171.2-132.3-6.078.4-1659.639.940.525.435.128.714.6
EV / EBITDA ····-239.040.452.777.3····
EV / FCF ····76.6-1540.436.239.7····
EV / Revenue ····14.58.27.33.8····
Dividend Yield ·0.00%0.00%0.23%0.39%0.86%1.1%1.1%1.3%2.9%3.4%3.2%
Earnings Yield -4.2%-6.4%-0.44%66.5%1.5%1.9%16.3%4.7%2.9%-7.4%1.8%4.4%
Payout Ratio ·0.00%·0.35%26.8%45.5%6.6%24.3%44.6%-39.6%189.8%72.9%
Annual Payout ·$0$0$7M$30M$30M$29M$28M$28M$28M$27M$23M

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue $594M · · · $573M
Gross Margin % 45.5% · · · 40.1%
Operating Margin % -4.5% · · · -30.6%
Net Income $-56M · · · $-165M
Diluted EPS $-1.22 · · · $-3.10

Institutional owners (13F) 271 filers · $1.4B total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 271
Value held $1.4B
New positions 47
Exited positions 48
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
47 (-2 vs prior Q) 48 (-21 vs prior Q) 97 (+7 vs prior Q) 79 (-10 vs prior Q) -2.4M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
BlackRock, Inc. $192,151,572 7,529,450 13.53% Shares
VANGUARD GROUP INC $150,965,344 4,538,946 10.63% Shares
Politan Capital Management LP $117,964,924 4,622,450 8.30% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $63,642,899 2,493,844 4.48% Shares
VANGUARD CAPITAL MANAGEMENT LLC $47,726,840 1,870,174 3.36% Shares
STATE STREET CORP $47,465,208 1,859,945 3.34% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $36,335,836 1,423,818 2.56% Shares
D. E. Shaw & Co., Inc. $34,226,506 1,341,164 2.41% Shares
MORGAN STANLEY $33,946,572 1,330,194 2.39% Shares
Front Street Capital Management, Inc. $33,211,677 1,301,398 2.34% Shares
DIMENSIONAL FUND ADVISORS LP $31,452,974 1,232,473 2.21% Shares
Allspring Global Investments Holdings, LLC $31,218,689 1,192,008 2.20% Shares
NEUBERGER BERMAN GROUP LLC $28,878,016 1,131,616 2.03% Shares
GEODE CAPITAL MANAGEMENT, LLC $28,099,240 1,100,849 1.98% Shares
AMERICAN CAPITAL MANAGEMENT INC $27,089,225 1,061,490 1.91% Shares
ROYCE & ASSOCIATES LP $22,749,013 891,419 1.60% Shares
SNYDER CAPITAL MANAGEMENT L P $22,267,323 872,544 1.57% Shares
VICTORY CAPITAL MANAGEMENT INC $21,794,208 854,005 1.53% Shares
AMERIPRISE FINANCIAL INC $19,600,610 768,049 1.38% Shares
BANK OF AMERICA CORP /DE/ $17,057,516 668,398 1.20% Shares
SYSTEMATIC FINANCIAL MANAGEMENT LP $16,589,429 650,055 1.17% Shares
CITADEL ADVISORS LLC $15,207,470 595,904 1.07% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $15,030,616 588,974 1.06% Shares
SEGALL BRYANT & HAMILL, LLC $14,120,165 553,298 0.99% Shares
SCHRODER INVESTMENT MANAGEMENT GROUP $13,695,707 536,876 0.96% Shares
Nuveen, LLC $13,535,476 530,387 0.95% Shares
SILVERCREST ASSET MANAGEMENT GROUP LLC $13,388,732 524,635 0.94% Shares
NORTHERN TRUST CORP $12,361,581 484,388 0.87% Shares
JUPITER ASSET MANAGEMENT LTD $12,101,099 474,181 0.85% Shares
Rock Springs Capital Management LP $10,284,560 403,000 0.72% Shares
Quantinno Capital Management LP $10,101,531 395,828 0.71% Shares
GOLDMAN SACHS GROUP INC $9,990,365 391,472 0.70% Shares
UBS Group AG $9,829,436 385,166 0.69% Shares
Man Group plc $9,402,053 368,419 0.66% Shares
PALISADE CAPITAL MANAGEMENT, LP $7,551,317 295,898 0.53% Shares
Kerrisdale Advisers, LLC $7,418,205 290,682 0.52% Shares
AQR CAPITAL MANAGEMENT LLC $7,313,111 292,876 0.51% Shares
BNP PARIBAS FINANCIAL MARKETS $7,108,596 278,550 0.50% Shares
VANGUARD FIDUCIARY TRUST CO $6,949,887 272,331 0.49% Shares
NEW YORK STATE COMMON RETIREMENT FUND $6,879,682 269,580 0.48% Shares
Bank of New York Mellon Corp $6,818,074 267,166 0.48% Shares
JPMORGAN CHASE & CO $6,257,220 243,498 0.44% Shares
FEDERATED HERMES, INC. $5,824,276 228,224 0.41% Shares
NORDEA INVESTMENT MANAGEMENT AB $5,678,489 226,958 0.40% Shares
Meros Investment Management, LP $5,625,399 220,431 0.40% Shares
Edgestream Partners, L.P. $5,504,128 215,679 0.39% Shares
NORGES BANK $5,479,144 214,700 0.39% Shares
COMERICA BANK $5,378,642 161,715 0.38% Shares
CAXTON ASSOCIATES LLP $5,268,987 206,465 0.37% Shares
Invesco Ltd. $5,160,221 202,203 0.36% Shares

Show all 271 institutional owners →

Activists & 5%+ owners 16 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Politan Capital Management LP, Politan Capital Management GP LLC, Politan Capital Partners GP LLC, Quentin Koffey ×4 filings Nov. 4, 2024 · Initial filing Board campaign SEC
The D3 Family Fund, L.P., The D3 Family Bulldog Fund, L.P., The D3 Family Canadian Fund, L.P., The DIII Offshore Fund, L.P., Nierenberg Investment Management Company, Inc., Nierenberg Investment Management Offshore, Inc., David Nierenberg ×2 filings April 7, 2010 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Feb. 9, 2009 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Oct. 7, 2008 · Initial filing Capital structure SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person June 16, 2008 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Sept. 26, 2007 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Jan. 29, 2007 · Initial filing Board campaign SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person July 6, 2006 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Jan. 17, 2006 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Dec. 30, 2005 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Dec. 9, 2005 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person Dec. 9, 2005 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person July 15, 2005 · Initial filing · SEC
Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person, Undisclosed reporting person July 12, 2005 · Initial filing · SEC
Undisclosed reporting person Nov. 2, 2001 · Initial filing M&A / sale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 76 insiders · 50 officers · 28 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Martin D Madaus Interim CEO Sept. 22, 2026 F 42,602 0 0 $0
John Marotta President and CEO Nov. 24, 2025 A 213,194 1 0 $25,990
Stephen S Schwartz CEO Nov. 16, 2023 A 446,536 0 0 $0
Robert Lepofsky Chief Executive Officer Sept. 30, 2010 F 881,995 0 0 $0
Edward C Grady Chief Executive Officer Sept. 30, 2007 F 96,200 0 0 $0
Lawrence Y. Lin EVP, CFO and Treasurer Sept. 14, 2026 A 110,199 0 0 $0
Herman Cueto EVP, Chief Financial Officer Nov. 19, 2024 S 23,892 0 0 $0
Lindon G Robertson EVP & Chief Financial Officer Nov. 16, 2023 D 121,081 0 0 $0
Martin S Headley EVP & Chief Financial Officer Feb. 4, 2013 F 506,741 0 0 $0
Robert W Woodbury JR Executive VP & CFO Dec. 31, 2007 D 79,643 0 0 $0
William E. Martin III President Multiomics Sept. 14, 2026 A 33,062 0 0 $0
David Jarzynka President, Semi Solutions Nov. 19, 2021 S 46,315 0 0 $0
Guojuan Liao President, GENEWIZ Nov. 18, 2020 S 12,827 0 0 $0
Maurice H. Tenney President-Brooks Life Sciences Feb. 15, 2019 S 136,556 0 0 $0
Mark D Morelli President and COO Nov. 6, 2015 A 414,944 0 0 $0
Ralf K Wuellner President, Global Cust Op Grp June 8, 2009 S 37,750 0 0 $0
Michael W Pippins President, Automation Sys. Grp Jan. 23, 2009 D 20,397 0 0 $0
James Gentilcore President & COO Nov. 30, 2007 J 16,561 0 0 $0
Joseph Bellini President & COO March 1, 2007 M 29,233 0 0 $0
Matthew Mcmanus EVP & Chief Operating Officer Aug. 19, 2022 P 29,467 0 0 $0
Erik J. Bello VP Chief Accounting Officer Sept. 15, 2026 A 4,586 0 0 $0
Ephraim Starr SVP, Gen Counsel & Secretary Sept. 14, 2026 A 84,000 1 0 $8,097
Olga Pirogova SVP and CHRO Sept. 14, 2026 A 47,225 0 1 $-30,966
Ginger Zhou SVP and GM, Multiomics Nov. 24, 2025 A 38,755 0 1 $-30,966
Violetta Hughes VP, Chief Accounting Officer Feb. 3, 2025 S 9,603 0 0 $0
David Dong Wang SVP & GM, SMS Dec. 4, 2024 D 23,974 0 0 $0
Jason Joseph SVP, General Counsel, Secy. Nov. 19, 2024 S 112,564 0 0 $0
Robin Vacha SVP, GM Life Science Products Jan. 31, 2024 A 31,438 0 0 $0
David C Gray Chief Strategy & New Business Nov. 17, 2023 D 74,868 0 0 $0
Vandana Sriram SVP Finance & Corp. Controller Jan. 31, 2023 A 6,356 0 0 $0
Kimberly Crowley SVP, Chief HR Officer Jan. 31, 2023 A 7,399 0 0 $0
Mitchell Coyne SVP and GM, Life Sciences Proj Nov. 17, 2022 A 1,889 0 0 $0
Linda De Jesus Chief Commercial Officer, LS July 29, 2022 A 2,764 0 0 $0
David Pietrantoni Principal Accounting Officer Nov. 17, 2021 S 27,375 0 0 $0
William T. Montone SVP, Human Resources Sept. 27, 2021 S 91,936 0 0 $0
Kush Mirchandani SVP, Worldwide Sales Dec. 4, 2013 S 120,792 0 0 $0
Clinton M. Haris SVP, Brooks Life Sciences Nov. 8, 2013 F 151,374 0 0 $0
Timothy S Mathews Principal Accounting Officer May 23, 2013 S 55,846 0 0 $0
Michaud A. Steven SVP, Brooks Product Solutions Nov. 8, 2012 F 221,215 0 0 $0
John Lillig SVP, MD, Brooks Life Sciences July 31, 2012 J 81,500 0 0 $0
Sally White SVP, Global Services Feb. 3, 2012 F 85,684 0 0 $0
Gregory Marvell VP, Extended Factory Group Feb. 7, 2011 S 36,760 0 0 $0
Thomas S Grilk Sr. VP, General Counsel Oct. 1, 2010 S 70,288 0 0 $0
Shaun Wilson VP, Global Customer Operations Aug. 6, 2010 F 71,891 0 0 $0
Richard Small SVP, Corporate Controller Dec. 20, 2007 F 36,122 0 0 $0
Robert E Anastasi Executive Vice President Oct. 26, 2007 J 10,824 0 0 $0
Peter Frasso SVP Feb. 11, 2005 D 0 0 0 $0
Jeffrey A Cassis SVP, Global Sales and Service July 31, 2004 J 629 0 0 $0
Steven P Wentzell SVP, Human Resources Nov. 5, 2003 M 0 0 0 $0
Santo Dinaro SVP, Hardware Automation Group Oct. 16, 2003 A · 0 0 $0
William L Cornog Director May 18, 2026 P 19,703 4 0 $353,684
Tina Susan Nova Director Feb. 6, 2026 A 15,772 0 0 $0
Quentin Koffey Director Feb. 5, 2026 A 10,698 0 0 $0
Frank Casal Director Feb. 5, 2026 A 21,803 0 0 $0
Erica Mclaughlin Director Feb. 5, 2026 A 22,521 0 0 $0
Dipal Doshi Director Feb. 5, 2026 A 9,703 0 0 $0
Robyn C Davis Director Feb. 5, 2026 A 33,627 0 0 $0
Alan J Malus Director May 30, 2025 P 17,035 1 0 $319,800
Didier Hirsch Director Nov. 18, 2024 P 3,465 0 0 $0
Michael Rosenblatt Director Feb. 12, 2024 A 13,042 0 0 $0
Edward Peter Bousa Director Feb. 12, 2024 A 2,465 0 0 $0
Ellen M Zane Director Aug. 8, 2023 A 41,134 0 0 $0
Joseph R Martin Director June 6, 2023 S 85,175 0 0 $0
Krishna G. Palepu Director Feb. 13, 2023 A 105,393 0 0 $0
Dorothy E Puhy Director Feb. 13, 2023 A 3,604 0 0 $0
Alfred Woollacott III Director Feb. 11, 2022 A 81,736 0 0 $0
Mark S Wrighton Director Feb. 11, 2022 A 111,818 0 0 $0
Clinton A Allen Director Sept. 25, 2020 A 82,127 0 0 $0
Kirk P Pond Director Dec. 20, 2019 A 49,145 0 0 $0
John K Mcgillicuddy Director Jan. 29, 2018 A 9,500 0 0 $0
Chong Sup Park Director Dec. 20, 2012 M 36,645 0 0 $0
Amin J Khoury Director April 12, 2006 D 7,220 0 0 $0
Roger D Emerick Director April 10, 2006 D 14,000 0 0 $0
Robert J Therrien Director Dec. 22, 2005 G 716,828 0 0 $0
Thomas Leitzke · Aug. 5, 2013 F 139,819 0 0 $0
Marvin G Schorr · Feb. 10, 2011 A 158,828 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 47 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
PSCH · Invesco Exchange-Traded Fund Trust … 0.74% 37,990 SH Oct. 1, 2026 Daily
QQQS · Invesco Exchange-Traded Fund Trust … 0.55% 3,656 SH Oct. 1, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.12% 94,304 SH Oct. 1, 2026 Daily
QVMS · Invesco Exchange-Traded Fund Trust … 0.10% 6,704 SH Oct. 1, 2026 Daily
NUSC · Nushares ETF Trust 0.09% 39,458 NS July 31, 2026 N-PORT
ESML · iShares Trust 0.08% 76,593 SH Sept. 11, 2026 Daily
FYX · First Trust Exchange-Traded AlphaDE… 0.07% 34,182 NS July 31, 2026 N-PORT
VIOG · VANGUARD ADMIRAL FUNDS 0.07% 29,298 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.07% 36,650 SH Aug. 19, 2026 Daily
DFSV · Dimensional ETF Trust 0.06% 181,106 NS July 31, 2026 N-PORT
VIOO · VANGUARD ADMIRAL FUNDS 0.06% 144,321 SH Aug. 19, 2026 Daily
RWJ · Invesco Exchange-Traded Fund Trust … 0.05% 26,070 SH Oct. 1, 2026 Daily
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.04% 10,453 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.04% 1,078,212 SH Sept. 11, 2026 Daily
VIOV · VANGUARD ADMIRAL FUNDS 0.04% 34,819 SH Aug. 19, 2026 Daily
ISCG · iShares Trust 0.04% 12,320 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.04% 20,073 NS July 31, 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.03% 241,860 SH Aug. 19, 2026 Daily
VBR · VANGUARD INDEX FUNDS 0.02% 602,767 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.02% 125,433 SH Aug. 19, 2026 Daily
OMFS · Invesco Exchange-Traded Self-Indexe… 0.02% 1,483 SH Oct. 1, 2026 Daily
DFAS · Dimensional ETF Trust 0.02% 105,742 NS July 31, 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0.02% 19,310 NS July 31, 2026 N-PORT
DXUV · Dimensional ETF Trust 0.01% 2,453 NS July 31, 2026 N-PORT
WSML · iShares Trust 0.01% 2,569 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.01% 470,383 SH Aug. 19, 2026 Daily
VB · VANGUARD INDEX FUNDS 0.01% 954,583 SH Aug. 19, 2026 Daily
DFAC · Dimensional ETF Trust 0.01% 114,518 NS July 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.00% 5,381 NS July 31, 2026 N-PORT
DFUV · Dimensional ETF Trust 0.00% 20,442 NS July 31, 2026 N-PORT
ITOT · iShares Trust 0.00% 69,061 SH Sept. 11, 2026 Daily
DFUS · Dimensional ETF Trust 0.00% 15,737 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.00% 8,077 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.00% 10,778 SH Sept. 4, 2026 Daily
TILT · FlexShares Trust 0.00% 158 NS July 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 1,321,722 SH Aug. 19, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 36,169 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 3,607 SH Aug. 19, 2026 Daily
ESGV · VANGUARD WORLD FUND 0.00% 9,411 SH Aug. 19, 2026 Daily
IJR · iShares Trust · 2,502,470 SH Sept. 10, 2026 Daily
IJT · iShares Trust · 233,730 SH Sept. 9, 2026 Daily
IJS · iShares Trust · 146,686 SH Sept. 8, 2026 Daily
IWN · iShares Trust · 392,015 SH Sept. 11, 2026 Daily
XJR · iShares Trust · 5,654 SH Aug. 31, 2026 Daily
SVAL · iShares Trust · 24,763 SH Sept. 3, 2026 Daily
ISCB · iShares Trust · 1,702 SH Sept. 11, 2026 Daily
SMLF · iShares Trust · 45,113 SH Sept. 11, 2026 Daily

AZTA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 13 analysts BUY
Median target $35.50 -8.4%
3 23.1% Strong Buy
6 46.2% Buy
4 30.8% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

4 analysts · 2026-09-28

Mean target $35.25 -9.0%

Above all targets → Current price $38.75
Low$33.00 Mean$35.25 High$37.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
AZTA $1.32B -23.5 3.5% -9.4% -3.3% 45.5%
ALMR · · · · · ·
MRVI · -3.6 -28.3% -70.4% -48.6% 18.3%
FTRE $1.61B -1.6 1.0% -36.2% -171.1% ·
BLFS · -241.8 28.9% · · ·
PSNL $816M -8.7 -17.7% -116.7% -36.0% ·
CYRX $479M 6.9 12.4% 44.4% 15.3% 47.1%
DNA $484M -1.5 -25.1% -183.8% -55.8% ·
PACB $565M -1.0 3.9% -341.5% -1634.9% 28.6%
CTKB $649M 505.0 0.52% -33.0% -18.5% 51.8%
MLAB $489M 73.1 3.4% 2.7% 3.7% 63.5%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 6, 2026